No environment is constant over time, and environmental fluctuations impact the outcome of
evolutionary dynamics. Survival of a population not adapted to some environmental …

It is unclear whether suboptimal adherence contributes to adverse clinical outcomes in
patients with chronic hepatitis B (CHB). Moreover, there is no consensus regarding the …

Objective To evaluate medication adherence among patients with hepatitis B-related
cirrhosis who developed decompensation and mortality, and to examine the association …

The emergence of drug resistance during antimicrobial therapy is a major global health
problem, especially for chronic infections like human immunodeficiency virus, hepatitis B …

Background & Aims: The dynamics of HBV viral load (VL) in patients with chronic hepatitis B
(CHB) on nucleos/tide analogue (NA) treatment and its relationship with liver disease are …

Background There are no longitudinal studies on the epidemiology of primary biliary
cholangitis (PBC) in Korea. This study aimed to elucidate the temporal trends in the …

Background Nonadherence to antiviral therapy can lead to poor clinical outcomes among
patients with chronic hepatitis B (CHB). We used a claims database to evaluate risk factors …

No environment is constant over time, and environmental fluctuations impact the outcome of
evolutionary dynamics. Survival of a population not adapted to some environmental …

Background About three hundred fifty to four hundred million people are infected chronically
with hepatitis B worldwide and about 780,000 people die annually of its complications …

Background: Non-adherence to anti-viral therapy can lead to poor clinical outcomes among
patients with chronic hepatitis B (CHB). We used a claims database to evaluate risk factors …